Component

Postprandial insulin incremental area under the curve

Postprandial insulin incremental area under the curve. Species, exposure and limitations are retained in each linked claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Oat beta-glucan reduced glucose incremental area under the curve and incremental peak rise by 23% and 28% and insulin by 22% and 24% respectively, dose, molecular weight and comparator were significant effect modifiers of glucose incremental area under the curve and peak, significant linear dose-response relationships were observed for all outcomes, oat beta-glucan molecular weight above 300 kg/mol significantly reduced glucose measures whereas molecular weight below 300 kg/mol did not, outcomes were similar in participants with and without diabetes, and all outcomes had high certainty of evidence.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/glucan-research/33608654.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7", "start_char": 0, "end_char": 1872, "text_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7"}
    experimental_model
    Systematic review and meta-analysis of 103 acute crossover trial comparisons in 538 participants
    exposure
    Oat beta-glucan concentrate or oat bran added to carbohydrate-containing test meals against carbohydrate-matched controls
    limitations
    Acute meal responses with high certainty of evidence by GRADE. The magnitude depends on dose, molecular weight and which control meal is used, so a pooled percentage is not a prediction for any particular food.
    nutrient_topic
    Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
    organism
    Human
    plain_language
    Adding it to a meal takes about a quarter off the glucose rise, but only if the polymer is long enough.
    primary_references
    [bg-p33608654] The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. (2021). https://pubmed.ncbi.nlm.nih.gov/33608654/ DOI: 10.1038/s41430-021-00875-9
    tissue_or_cell_type
    Postprandial glucose and insulin

    Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22) · lines 567–578

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Systematic review and meta-analysis of 103 acute crossover trial comparisons in 538 participants · source_derived_draft · unverified_draft

    ### bg-acute-glycaemic-response-falls Oat beta-glucan reduced glucose incremental area under the curve and incremental peak rise by 23% and 28% and insulin by 22% and 24% respectively, dose, molecular weight and comparator were significant effect modifiers of glucose incremental area under the curve and peak, significant linear dose-response relationships were observed for all outcomes, oat beta-glucan molecular weight above 300 kg/mol significantly reduced glucose measures whereas molecular weight below 300 kg/mol did not, outcomes were similar in participants with and without diabetes, and all outcomes had high certainty of evidence. Condition category: normal nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: Adding it to a meal takes about a quarter off the glucose rise, but only if the polymer is long enough. organism: Human tissue_or_cell_type: Postprandial glucose and insulin experimental_model: Systematic review and meta-analysis of 103 acute crossover trial comparisons in 538 participants limitations: Acute meal responses with high certainty of evidence by GRADE. The magnitude depends on dose, molecular weight and which control meal is used, so a pooled percentage is not a prediction for any particular food. exposure: Oat beta-glucan concentrate or oat bran added to carbohydrate-containing test meals against carbohydrate-matched controls evidence_span: {"source_cache": "artifacts/glucan-research/33608654.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7", "start_char": 0, "end_char": 1872, "text_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7"} [bg-p33608654] The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. (2021). https://pubmed.ncbi.nlm.nih.gov/33608654/ DOI: 10.1038/s41430-021-00875-9
    Complete structured claim and evidence
  2. Compared with the control cereal, 4 grams of oat beta-glucan significantly reduced glucose incremental area under the curve at 78 compared with 135 mmol x min/L and insulin at 14.0 compared with 26.8 nmol x min/L and delayed gastric emptying half-time to a geometric mean of 285 minutes compared with 105 minutes, effects not seen after the beta-glucanase-treated arm of the same dose, while subjective appetite, PYY and ghrelin responses were similar to control and pizza intakes at a subsequent unrestricted meal were not significantly different.

    Experimental context and source evidence
    availability_state
    biomarker_context Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/glucan-research/31828287.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70", "start_char": 0, "end_char": 2204, "text_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70"}
    experimental_model
    Double-blind randomised crossover trial in 28 participants with gastric emptying, appetite hormones and an unrestricted test lunch
    exposure
    Breakfast meals matched for weight, energy and macronutrients containing 2 or 4 grams of oat beta-glucan, or 4 grams treated with beta-glucanase to reduce molecular weight and viscosity
    limitations
    The beta-glucanase arm is the control that isolates viscosity. The trial was designed around food intake as the primary endpoint and found no effect on it.
    nutrient_topic
    Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
    organism
    Human
    plain_language
    The intact polymer held the meal in the stomach nearly three times longer; the same dose chopped up did nothing.
    primary_references
    [bg-p31828287] Increasing oat β-glucan viscosity in a breakfast meal slows gastric emptying and reduces glycemic and insulinemic responses but has no effect on appetite, food intake, or plasma ghrelin and PYY responses in healthy humans: a randomized, placebo-controlled, crossover trial. (2020). https://pubmed.ncbi.nlm.nih.gov/31828287/ DOI: 10.1093/ajcn/nqz285
    tissue_or_cell_type
    Stomach and postprandial circulation
    trigger_kind
    biomarker_context Imported condition classification; unverified.

    Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22) · lines 580–591

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind randomised crossover trial in 28 participants with gastric emptying, appetite hormones and an unrestricted test lunch · source_derived_draft · unverified_draft

    ### bg-viscosity-slows-the-stomach Compared with the control cereal, 4 grams of oat beta-glucan significantly reduced glucose incremental area under the curve at 78 compared with 135 mmol x min/L and insulin at 14.0 compared with 26.8 nmol x min/L and delayed gastric emptying half-time to a geometric mean of 285 minutes compared with 105 minutes, effects not seen after the beta-glucanase-treated arm of the same dose, while subjective appetite, PYY and ghrelin responses were similar to control and pizza intakes at a subsequent unrestricted meal were not significantly different. Condition category: biomarker_context nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: The intact polymer held the meal in the stomach nearly three times longer; the same dose chopped up did nothing. organism: Human tissue_or_cell_type: Stomach and postprandial circulation experimental_model: Double-blind randomised crossover trial in 28 participants with gastric emptying, appetite hormones and an unrestricted test lunch limitations: The beta-glucanase arm is the control that isolates viscosity. The trial was designed around food intake as the primary endpoint and found no effect on it. exposure: Breakfast meals matched for weight, energy and macronutrients containing 2 or 4 grams of oat beta-glucan, or 4 grams treated with beta-glucanase to reduce molecular weight and viscosity evidence_span: {"source_cache": "artifacts/glucan-research/31828287.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70", "start_char": 0, "end_char": 2204, "text_sha256": "983ae8675d933c4292f9f20059e93db94587b9a570fbfb602f5921f5bd7edd70"} [bg-p31828287] Increasing oat β-glucan viscosity in a breakfast meal slows gastric emptying and reduces glycemic and insulinemic responses but has no effect on appetite, food intake, or plasma ghrelin and PYY responses in healthy humans: a randomized, placebo-controlled, crossover trial. (2020). https://pubmed.ncbi.nlm.nih.gov/31828287/ DOI: 10.1093/ajcn/nqz285
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards